Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
CTOP for μ-Opioid Receptor Research
2026-08-11
CTOP provides a selective pharmacological switch for separating μ-opioid receptor effects from downstream circuit activity in binding, signaling, and pain-model experiments. This guide translates recent brain-to-spinal findings into practical assay designs, controls, and troubleshooting strategies for opioid receptor research.
-
Neurotensin: Designing Cleaner GPCR Assays
2026-08-11
Neurotensin is a powerful perturbation tool for studying NTR1 signaling, receptor recycling, and miR-133α modulation in gastrointestinal cells. This article presents a measurement-aware workflow that connects GPCR biology with fluorescence-interference control without confusing assay methodology with direct mechanistic evidence.
-
Capecitabine for Tumor-Stroma Drug Screening
2026-08-10
Capecitabine provides a practical way to investigate prodrug activation, tumor–stroma interactions, and treatment resistance in patient-derived models. This workflow shows how to deploy it in gastric assembloids and colon cancer research while separating validated findings from assay-specific optimization.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-09
Track mRNA uptake and EGFP translation in the same experiment with a dual-fluorescence reporter built for delivery optimization. This practical guide connects Cy5 imaging, functional expression, and LNP benchmarking to faster troubleshooting in macrophage and gene-delivery studies.
-
Capecitabine in Patient-Derived Gastric Assembloids
2026-08-08
Capecitabine offers a mechanistically informative way to study prodrug activation, stromal effects, and treatment response in patient-derived gastric assembloids. This article translates recent assembloid findings into practical assay decisions for preclinical oncology research while distinguishing evidence from experimental hypotheses.
-
Cy5 Hydrazide for Carbonyl Labeling
2026-08-07
Cy5 hydrazide is a carbonyl-reactive fluorescent dye for aldehyde and ketone biomolecule labeling, including protein carbonylation labeling and oxidative stress protein detection. Its far-red emission, strong reported extinction coefficient, and compatibility with SDS-PAGE workflows support sensitive carbonyl analysis, while low aqueous solubility requires an organic co-solvent.
-
TAK1 Stabilizes YAP to Promote Gastric Cancer Stem Cell Rene
2026-08-07
This study elucidates how TGFβ-activated kinase 1 (TAK1) enhances self-renewal and tumorigenic potential in gastric cancer stem cells by stabilizing yes-associated protein (YAP). The findings deepen mechanistic understanding of cancer stem cell maintenance, with implications for targeting chemoresistance and recurrence in solid tumor research.
-
Fluorouracil (Adrucil): Reliable Solutions for Solid Tumor A
2026-08-06
This article provides a scenario-driven, evidence-based guide to using Fluorouracil (Adrucil) (SKU A4071) in cell viability and cytotoxicity assays for solid tumor research. Drawing on validated protocols, published data, and practical lab experience, it highlights how this reagent delivers reproducible results and addresses common workflow challenges in colon and breast cancer models.
-
PSMD14-Driven CARM1 Stabilization Fuels HCC Progression via
2026-08-06
This study reveals that PSMD14-mediated deubiquitination stabilizes CARM1, driving proliferation and metastasis in hepatocellular carcinoma (HCC) by upregulating FERMT1 transcription. The findings highlight the CARM1-PSMD14 axis as a promising therapeutic target for HCC intervention.
-
Cimetidine in Advanced Blood-Brain Barrier and Cancer Resear
2026-08-05
Explore how Cimetidine, a histamine-2 receptor antagonist, is reshaping blood-brain barrier studies and gastrointestinal cancer research. This article uncovers new insights and protocols for leveraging Cimetidine’s unique pharmacology in translational assays.
-
TaqI Restriction Endonuclease: Fast DNA Digestion Workflows
2026-08-05
TaqI Restriction Endonuclease (SKU K3053) enables rapid, sequence-specific digestion of plasmid, PCR, or genomic DNA for molecular biology workflows demanding fast turnaround. It is optimized for research use and not intended for diagnostic or clinical applications.
-
Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In
2026-08-04
Wang et al. (2018) systematically dissected the entry pathway of type III grass carp reovirus (GCRV104), establishing that clathrin-mediated, pH-dependent endocytosis is crucial for viral uptake in host cells. The study leverages specific pharmacological inhibitors, including wortmannin, to clarify the distinct molecular mechanisms mediating viral entry, offering a foundation for antiviral strategy development.
-
Camptothecin: Topoisomerase I Inhibitor for DNA Damage Assay
2026-08-04
Camptothecin stands out as a precision tool for DNA damage, apoptosis, and autophagy workflows in cancer biology. This article delivers advanced protocol enhancements, troubleshooting insights, and connects the latest prion-based mutagenesis research to practical assay design.
-
Monomeric Amyloid Beta Regulates Microglial Inflammation via
2026-08-03
Kwon et al. (2023) reveal that monomeric amyloid beta (Aβ) acts as a potent inhibitor of microglial inflammatory activation in the developing brain, mediated through an APP/heterotrimeric G protein pathway. These findings challenge conventional views of amyloid beta solely as a pathogenic agent, opening new avenues for understanding immune regulation in Alzheimer’s disease.
-
Applied mRNA Delivery: EZ Cap™ Cy5 EGFP mRNA (5-moUTP) in Ac
2026-08-03
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers researchers to track mRNA delivery and translation with unparalleled dual-fluorescence visibility. Its immune-evasive chemistry and Cap 1 structure drive robust gene regulation studies while streamlining quantitative assays and nanoparticle validation.